For the year ending 2025-12-31, AMRX has $3,678,280K in assets. $282,029K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 282,029 | |||
| Restricted cash | 28,842 | |||
| Receivables-Nonrelated Party | 895,143 | |||
| Inventories | 606,302 | |||
| Prepaid expenses and other current assets | 98,395 | |||
| Receivables-Related Party | 470 | |||
| Total current assets | 1,911,181 | |||
| Property, plant and equipment, net | 442,950 | |||
| Goodwill | 595,470 | |||
| Net | 555,398 | |||
| In-process research and development | 8,100 | |||
| Intangible assets, net | 563,498 | |||
| Operating lease right-of-use assets-Nonrelated Party | 38,832 | |||
| Operating lease right-of-use assets-Related Party | 15,216 | |||
| Financing lease right of use assets-Nonrelated Party | 53,328 | |||
| Other assets | 57,805 | |||
| Total assets | 3,678,280 | |||
| Payable-Nonrelated Party | 761,316 | |||
| Current portion of liabilities for legal matters | 43,256 | |||
| Revolving credit facility | 0 | |||
| Current portion of long-term debt, net | 6,761 | |||
| Current portion of operating lease liabilities-Nonrelated Party | 8,668 | |||
| Current portion of operating lease liabilities-Related Party | 2,705 | |||
| Current portion of financing lease liabilities-Nonrelated Party | 3,442 | |||
| Payable-Related Party | 55,485 | |||
| Total current liabilities | 881,633 | |||
| Long-term debt, net | 2,565,115 | |||
| Operating lease liabilities-Nonrelated Party | 33,233 | |||
| Operating lease liabilities-Related Party | 14,195 | |||
| Financing lease liabilities-Nonrelated Party | 54,927 | |||
| Other long-term liabilities-Related Party | 19,132 | |||
| Liabilities for legal matters - long term | 71,819 | |||
| Other long-term liabilities-Nonrelated Party | 32,263 | |||
| Total long-term liabilities | 2,790,684 | |||
| Redeemable non-controlling interests | 77,292 | |||
| Common stock-Common Class A | 3,146 | |||
| Common stock-Common Class B | 0 | |||
| Additional paid-in capital | 571,794 | |||
| Stockholders accumulated deficit | -535,005 | |||
| Accumulated other comprehensive loss | -110,729 | |||
| Total amneal pharmaceuticals, inc. stockholders deficiency | -70,794 | |||
| Non-controlling interests | -535 | |||
| Total stockholders deficiency | -71,329 | |||
| Total liabilities and stockholders deficiency | 3,678,280 | |||
Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX)